JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fowler, J. S.
Right arrow Articles by Alexoff, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowler, J. S.
Right arrow Articles by Alexoff, D.
Journal of Nuclear Medicine Vol. 43 No. 10 1331-1338
© 2002 by Society of Nuclear Medicine


Clinical Investigations

PET Imaging of Monoamine Oxidase B in Peripheral Organs in Humans

Joanna S. Fowler, PhD1, Jean Logan, PhD1, Gene-Jack Wang, MD2, Nora D. Volkow, MD2, Wei Zhu, PhD3, Dinko Franceschi, MD2, Naomi Pappas, MS2, Richard Ferrieri, PhD1, Colleen Shea, MS1, Victor Garza, MS1, Youwen Xu, MS1, Robert R. MacGregor, BS1, David Schlyer, PhD1, S. John Gatley, PhD2, Yu-Shin Ding, PhD1 and David Alexoff, BS1

1 Chemistry Department, Brookhaven National Laboratory, Upton, New York
2 Medical Department, Brookhaven National Laboratory, Upton, New York
3 Department of Applied Mathematics and Statistics, State University of New York Stony Brook, Stony Brook, New York

Monoamine oxidase (MAO) regulates neurotransmitter concentration in the brain and is also an important detoxifying enzyme in peripheral organs. It occurs in 2 subtypes, MAO A and MAO B. Their relative ratios in different organs are variable, depending on the particular organ and species, making it difficult to extrapolate measures from animals to humans. The purpose of this study was to investigate the feasibility of imaging MAO B in peripheral organs in humans with PET. Methods: Nine healthy subjects (7 males, 2 females; mean age ± SD, 37 ± 7 y) received 2 dynamic PET studies of the torso area 2 h apart with 11C-L-deprenyl and deuterium-substituted 11C-L-deprenyl (11C-L-deprenyl-D2). Time-activity curves for heart, lungs, liver, kidneys, and spleen and arterial plasma input were measured for each study. The uptake at plateau and the incorporation quotient (IQ = uptake/plasma input) as well as model terms K1 (which is a function of blood flow) and k3 and {lambda}k3 (which are kinetic terms proportional to MAO B) were compared to identify organs that showed reduced values with deuterium substitution (deuterium isotope effect) characteristic of MAO B. In addition, a sensitivity analysis compared the 2 tracers with respect to their ability to quantify MAO B. Results: Heart, lungs, kidneys, and spleen showed a robust deuterium isotope effect on uptake, IQ, k3, and {lambda}k3. The arterial plasma input function was significantly larger for 11C-L-deprenyl-D2 than for 11C-L-deprenyl. Liver time-activity curves were not affected by deuterium substitution and model terms could not be estimated. In organs showing an isotope effect, {lambda}k3 showed the rank order: kidneys >= heart > lungs = spleen. A sensitivity analysis showed that 11C-L-deprenyl-D2 is a better index of MAO activity than 11C-L-deprenyl. Conclusion: This study demonstrates that (a) the deuterium isotope effect is useful in assessing the binding specificity of labeled deprenyl to peripheral MAO B; (b) MAO B can be visualized and quantified in the heart, lungs, kidneys, and spleen but not in the liver; (c) with the exception of the liver, which cannot be measured, MAO B activity is highest in the kidneys and heart; and (d) quantitation in organs having high levels of MAO B is improved by the use of 11C-L-deprenyl-D2, similar to prior studies on the brain. This study indicates that 11C-L-deprenyl-D2 will be useful for measuring the effects of different variables, including tobacco smoke exposure on MAO B activity in peripheral organs in humans.

Key Words: PET • monoamine oxidase B • peripheral organs




This article has been cited by other articles:


Home page
JNMHome page
R. M. Baldwin
Imaging MAO-A Levels by PET Using the Deuterium Isotope Effect
J. Nucl. Med., September 1, 2005; 46(9): 1411 - 1413.
[Full Text] [PDF]


Home page
JNMHome page
J. S. Fowler, J. Logan, G.-J. Wang, N. D. Volkow, F. Telang, W. Zhu, D. Franceschi, C. Shea, V. Garza, Y. Xu, et al.
Comparison of Monoamine Oxidase A in Peripheral Organs in Nonsmokers and Smokers
J. Nucl. Med., September 1, 2005; 46(9): 1414 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Fowler, J. Logan, G.-J. Wang, N. D. Volkow, F. Telang, W. Zhu, D. Franceschi, N. Pappas, R. Ferrieri, C. Shea, et al.
Inaugural Article: Low monoamine oxidase B in peripheral organs in smokers
PNAS, September 30, 2003; 100(20): 11600 - 11605.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.